Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer

Table 1

6 KRAS-associated metabolic genes to establish the risk model.

Genes	coef	HR	HR.95L	HR.95H	value
CYP2S1	-0.29328	0.74582	0.60422	0.92060	0.00633
GPX3	-0.45614	0.63372	0.47754	0.84098	0.00158
FTCD	-0.57665	0.56178	0.44136	0.71504	2.80-06
ENPP2	0.54899	1.73150	1.2754	2.3506	0.000432
UGT1A10	0.19472	1.21498	1.0496	1.4064	0.00911
XDH	0.34727	1.41520	1.1314	1.7702	0.00236